{"id":39803,"date":"2022-03-21T08:49:48","date_gmt":"2022-03-21T08:49:48","guid":{"rendered":"http:\/\/cryptospotters.net\/?p=39803"},"modified":"2022-03-21T08:49:48","modified_gmt":"2022-03-21T08:49:48","slug":"astrazeneca-covid-19-drug-neutralises-omicron-sub-variants-says-lab-studyunited-states-canada-south-china-morning-post","status":"publish","type":"post","link":"http:\/\/cryptospotters.net\/?p=39803","title":{"rendered":"AstraZeneca Covid-19 drug neutralises Omicron sub-variants, says lab studyUnited States &amp; Canada &#8211; South China Morning Post"},"content":{"rendered":"<p>Source: United States &amp; Canada &#8211; South China Morning PostAstraZeneca said on Monday its antibody-based cocktail to prevent and treat Covid-19 retained neutralising activity against Omicron coronavirus variants, including the highly contagious BA. 2 sub-variant, in an independent lab study.This is the first data looking at the impact of AstraZeneca\u2019s Evusheld treatment on \u201ccousins\u201d of the Omicron variant following a recent global spike in cases. The Anglo-Swedish drug maker said in December that another lab study found that Evusheld retained\u2026<a href=\"https:\/\/www.scmp.com\/news\/world\/europe\/article\/3171259\/astrazeneca-covid-19-drug-neutralises-omicron-sub-variants-says?utm_source=rss_feed\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Source: United States &amp; Canada &#8211; South China Morning PostAstraZeneca said on Monday its antibody-based cocktail to prevent and treat Covid-19 retained neutralising activity against Omicron coronavirus variants, including the&hellip; <\/p>\n","protected":false},"author":0,"featured_media":39804,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"http:\/\/cryptospotters.net\/index.php?rest_route=\/wp\/v2\/posts\/39803"}],"collection":[{"href":"http:\/\/cryptospotters.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/cryptospotters.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"http:\/\/cryptospotters.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=39803"}],"version-history":[{"count":0,"href":"http:\/\/cryptospotters.net\/index.php?rest_route=\/wp\/v2\/posts\/39803\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/cryptospotters.net\/index.php?rest_route=\/wp\/v2\/media\/39804"}],"wp:attachment":[{"href":"http:\/\/cryptospotters.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=39803"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/cryptospotters.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=39803"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/cryptospotters.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=39803"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}